These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13207562)

  • 1. Polyvalent antivenin in treatment of experimental snake venom poisoning.
    MINTON SA
    Am J Trop Med Hyg; 1954 Nov; 3(6):1077-82. PubMed ID: 13207562
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous antivenin in clinical snake venom poisoning. A preliminary report.
    PARRISH HM
    Mo Med; 1963 Mar; 60():240-4. PubMed ID: 13941591
    [No Abstract]   [Full Text] [Related]  

  • 3. [Paraspecificity of antivenins: example of severe envenomation by the Sahara horned viper (Cerastes cerastes) treated with non-specific antivenin].
    Aissaoui Y; Kichna H; Boughalem M; Drissi Kamili N
    Med Sante Trop; 2013; 23(1):100-3. PubMed ID: 23695188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IMMUNOLOGICAL STUDIES ON SNAKE VENOM. I. COMPARISON OF VENOMS FROM GENUS TRIMERESURUS INHABITING THE RYUKYU ISLANDS].
    SADAHIRO S; YAMAUCHI K; KONDO S; KONDO H; MURATA R
    Nihon Saikingaku Zasshi; 1965 Jan; 20():21-6. PubMed ID: 14295690
    [No Abstract]   [Full Text] [Related]  

  • 5. Further studies on the immunogenic properties of photooxidized Formosan snake venoms, with special reference to a trial preparation of polyvalent antivenin using photooxidized multiple venom antigens--second report.
    Huang CT; Huang JS; Ling KH; Lin SY
    Taiwan Yi Xue Hui Za Zhi; 1973 Apr; 72(4):208-17. PubMed ID: 4515138
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of polyvalent antivenin against Trimeresurus flavoviridis and Agkistrodon blomhoffii venoms.
    BURNS KF
    Am J Trop Med Hyg; 1951 Sep; 31(5):665-8. PubMed ID: 14878113
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterologous antivenin in neutralization of North American coral snake venom.
    KEEGAN HL; WHITTEMORE FW; FLANIGAN JF
    Public Health Rep (1896); 1961 Jun; 76(6):540-2. PubMed ID: 13752144
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute pulmonary edema as a complication of anti-snake venom therapy.
    Singh A; Biswal N; Nalini P; Sethuraman ; Badhe A
    Indian J Pediatr; 2001 Jan; 68(1):81-2. PubMed ID: 11237242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive hemagglutination studies with snake venom and antivenin.
    Boche RD; Russell FE
    Toxicon; 1968 Oct; 6(2):125-30. PubMed ID: 5721657
    [No Abstract]   [Full Text] [Related]  

  • 10. Snake venom poisoning in the United States.
    Russell FE
    Annu Rev Med; 1980; 31():247-59. PubMed ID: 6994610
    [No Abstract]   [Full Text] [Related]  

  • 11. [Avidity of sera-neutralizing snake venom].
    Abidov AA; Lisochenko LG; Zaidova SM
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):115-8. PubMed ID: 665016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snake and spider antivenin: risks and benefits of therapy.
    Weisman RS; Lizarralde SS; Thompson V
    J Fla Med Assoc; 1996 Mar; 83(3):192-5. PubMed ID: 8920051
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice.
    Consroe P; Egen NB; Russell FE; Gerrish K; Smith DC; Sidki A; Landon JT
    Am J Trop Med Hyg; 1995 Nov; 53(5):507-10. PubMed ID: 7485708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental study on the importance of early antivenin treatment in snake bite.
    SCHOTTLER WH
    Am J Trop Med Hyg; 1952 Nov; 1(6):1038-42. PubMed ID: 12996757
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risks posed by venomous animals -- accidents due to snakebite envenomation].
    Erkens K; Boecken G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Oct; 39(10):587-96. PubMed ID: 15486801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snake bite: clinical presentation, complication and outcome in relation to time of polyvalent snake antivenin in Yemen.
    Abohassan AM; Borham MM; Barshomy S
    J Egypt Soc Parasitol; 2012 Dec; 42(3):713-20. PubMed ID: 23469644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The painful experience of inappropriate therapy of snake bites: a report of two cases.
    Hung DZ; Wu TC; Deng JF
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Dec; 60(6):326-30. PubMed ID: 9531742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A focus on snake venoms and antivenins.
    Schaer M
    J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):458-60. PubMed ID: 22316193
    [No Abstract]   [Full Text] [Related]  

  • 20. Cross neutralization of common Southeast Asian viperid venoms by a Thai polyvalent snake antivenom (Hemato Polyvalent Snake Antivenom).
    Leong PK; Tan CH; Sim SM; Fung SY; Sumana K; Sitprija V; Tan NH
    Acta Trop; 2014 Apr; 132():7-14. PubMed ID: 24384454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.